Atraverse showcases findings indicating mitigated left atrial injury and reduced RF delivery with Hotwire...
Atraverse Medical has announced the presentation of new clinical and preclinical data at the 2026 AF symposium (5–7 February, Boston, USA), further validating the...
Abbott announces late-breaking data from global VOLT-AF and FOCALFLEX studies
Abbott has announced new clinical data from two late-breaking presentations at the 2026 AF symposium (5–7 February, Boston, USA) that demonstrate the safety and efficacy...
Argá Medtech reports 94% lesion durability and “strong safety profile” with single-catheter PFA system
Argá Medtech has announced positive clinical results from the BURST-AF first-in-human trial, demonstrating the safety, effectiveness and durability of its Coherent sine-burst electroporation (CSE)...
Field Medical presents late-breaking Field PULSE trial data at 2026 AF symposium
Field Medical has announced the presentation of late-breaking clinical trial data from the first-in-human Field PULSE study—which is evaluating the company’s FieldForce ablation system...
